Form 4: Pediatrix Medical Group CEO James D. Swift Sells Shares
SEC Form 4
James D. Swift, CEO of Pediatrix Medical Group, sold 11,100 shares of common stock at an average price of $10.79 on August 30, 2024.
Summary
- On August 30, 2024, James D. Swift, the Chief Executive Officer of Pediatrix Medical Group, Inc., sold 11,100 shares of the company's common stock.
- The sale was executed at a weighted average price of $10.79 per share.
- The prices for individual transactions ranged from $10.71 to $11.00.
- Following the transaction, Swift directly owns 170,001 shares of Pediatrix Medical Group, Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of an insider stock sale, which doesn't inherently indicate positive or negative sentiment about the company's future prospects.
Industry Context
This is a routine disclosure of an insider transaction. Insider sales can sometimes be interpreted negatively by the market, but without further context, it's difficult to assess the impact.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder confidence, depending on the broader market perception of the company.
Key Dates
| Date | Description |
|---|---|
| 08/30/2024 | Date of the transaction: James D. Swift sold 11,100 shares of Pediatrix Medical Group, Inc. |
| 09/03/2024 | Date of the report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.